JP2004527567A5 - - Google Patents

Download PDF

Info

Publication number
JP2004527567A5
JP2004527567A5 JP2002586947A JP2002586947A JP2004527567A5 JP 2004527567 A5 JP2004527567 A5 JP 2004527567A5 JP 2002586947 A JP2002586947 A JP 2002586947A JP 2002586947 A JP2002586947 A JP 2002586947A JP 2004527567 A5 JP2004527567 A5 JP 2004527567A5
Authority
JP
Japan
Prior art keywords
keto
compound
composition
prostaglandin
prostaglandin compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002586947A
Other languages
English (en)
Japanese (ja)
Other versions
JP4332353B2 (ja
JP2004527567A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2002/004223 external-priority patent/WO2002089812A1/en
Publication of JP2004527567A publication Critical patent/JP2004527567A/ja
Publication of JP2004527567A5 publication Critical patent/JP2004527567A5/ja
Application granted granted Critical
Publication of JP4332353B2 publication Critical patent/JP4332353B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002586947A 2001-05-02 2002-04-26 15−ケト−プロスタグランジン類を含む薬物誘発性便秘処置用組成物 Expired - Fee Related JP4332353B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28772001P 2001-05-02 2001-05-02
PCT/JP2002/004223 WO2002089812A1 (en) 2001-05-02 2002-04-26 Composition for treating drug-induced constipation with 15-keto-prostaglandins

Publications (3)

Publication Number Publication Date
JP2004527567A JP2004527567A (ja) 2004-09-09
JP2004527567A5 true JP2004527567A5 (US20040106767A1-20040603-C00005.png) 2005-11-17
JP4332353B2 JP4332353B2 (ja) 2009-09-16

Family

ID=23104042

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002586947A Expired - Fee Related JP4332353B2 (ja) 2001-05-02 2002-04-26 15−ケト−プロスタグランジン類を含む薬物誘発性便秘処置用組成物

Country Status (19)

Country Link
US (1) US6982283B2 (US20040106767A1-20040603-C00005.png)
EP (1) EP1392318B1 (US20040106767A1-20040603-C00005.png)
JP (1) JP4332353B2 (US20040106767A1-20040603-C00005.png)
KR (1) KR100886598B1 (US20040106767A1-20040603-C00005.png)
CN (1) CN1522147B (US20040106767A1-20040603-C00005.png)
AR (2) AR035237A1 (US20040106767A1-20040603-C00005.png)
AT (1) ATE355067T1 (US20040106767A1-20040603-C00005.png)
AU (1) AU2002251554B2 (US20040106767A1-20040603-C00005.png)
BR (1) BR0209327A (US20040106767A1-20040603-C00005.png)
CA (1) CA2444103C (US20040106767A1-20040603-C00005.png)
DE (1) DE60218451T2 (US20040106767A1-20040603-C00005.png)
DK (1) DK1392318T3 (US20040106767A1-20040603-C00005.png)
ES (1) ES2282408T3 (US20040106767A1-20040603-C00005.png)
MX (1) MXPA03010019A (US20040106767A1-20040603-C00005.png)
NO (1) NO335143B1 (US20040106767A1-20040603-C00005.png)
NZ (1) NZ529187A (US20040106767A1-20040603-C00005.png)
PT (1) PT1392318E (US20040106767A1-20040603-C00005.png)
TW (1) TWI302100B (US20040106767A1-20040603-C00005.png)
WO (1) WO2002089812A1 (US20040106767A1-20040603-C00005.png)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ531503A (en) 2001-08-31 2006-01-27 Sucampo Ag Prostaglandin analogs as chloride channel opener
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
ATE539756T1 (de) * 2002-10-23 2012-01-15 Sucampo Ag Prostaglandinsubstanzen für die behandlung von fettsucht
AU2003292556B2 (en) * 2002-12-27 2009-09-10 Sucampo Ag Derivatives of prostaglandins for treating abdominal discomfort
TWI387454B (zh) 2004-09-02 2013-03-01 Sucampo Ag 治療胃腸道疾病之方法及組成物
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US9662390B2 (en) * 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8524731B2 (en) * 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
PL1871380T3 (pl) * 2005-04-12 2012-03-30 Sucampo Ag Zastosowanie kombinacji związku prostaglandyny i inhibitora pompy protonowej w leczeniu zaburzeń żołądkowo-jelitowych
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
US9044510B2 (en) * 2007-11-01 2015-06-02 Washington University Compositions and methods for treating pruritus
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
US8957024B2 (en) 2011-07-27 2015-02-17 Washington University Composition and methods for reducing opioid-induced pruritus
KR20140052389A (ko) 2012-10-24 2014-05-07 주식회사 아리바이오 해양 심층수 또는 염지하수로부터 제조된 고경도의 미네랄 워터를 포함하는 변비 예방, 개선 또는 치료용 조성물
US20140116916A1 (en) 2012-10-31 2014-05-01 2294719 Ontario Limited Therapy for Constipation
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
CN105777601A (zh) * 2014-12-26 2016-07-20 中国人民解放军第二军医大学 一种前列地尔衍生物及其药物制剂
EP3436011A4 (en) * 2016-03-29 2019-12-04 Colonaryconcepts LLC FORMULATIONS FOR TREATMENT OF CONSTIPATION
US11534404B2 (en) 2016-10-06 2022-12-27 Sucampo Ag Multilayer beads for pharmaceutical use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1581886A (en) * 1977-05-26 1980-12-31 May & Baker Ltd Prostanol derivatives
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
GB2210556B (en) * 1987-10-02 1991-07-17 Ueno Seiyaku Oyo Kenkyujo Kk The use of 15-keto-16-halo-prostaglandins in cathartic compositions
US5317032A (en) 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
TW224942B (US20040106767A1-20040603-C00005.png) 1990-04-04 1994-06-11 Adka Ueno Kk
CA2041417C (en) * 1990-05-01 2002-05-21 Ryuji Ueno Treatment of pancreatic disease with 15-keto-prostaglandin compounds
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
KR19990036322A (ko) 1996-06-10 1999-05-25 류지 우에노 엔도텔린길항제
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
KR100867295B1 (ko) * 2001-05-18 2008-11-06 수캄포 아게 하제 조성물

Similar Documents

Publication Publication Date Title
JP2004527567A5 (US20040106767A1-20040603-C00005.png)
JP2008531468A5 (US20040106767A1-20040603-C00005.png)
JP2008528440A5 (US20040106767A1-20040603-C00005.png)
DK2592081T3 (en) TETRAHYDROCARBOLIN DERIVATIVES
CA2600331A1 (en) Use of 11-deoxy-prostaglandin for treating peripheral vascular diseases
CA2444103A1 (en) Composition for treating drug-induced constipation with 15-keto-prostaglandins
JP2005504836A5 (US20040106767A1-20040603-C00005.png)
JP2009521483A5 (US20040106767A1-20040603-C00005.png)
JP2006521359A5 (US20040106767A1-20040603-C00005.png)
RU2440338C2 (ru) Способ и композиция для лечения заболеваний центральной нервной системы
JP2006513232A5 (US20040106767A1-20040603-C00005.png)
JP2004507521A5 (US20040106767A1-20040603-C00005.png)
JP2008533195A5 (US20040106767A1-20040603-C00005.png)
EA200970582A1 (ru) ПРОИЗВОДНЫЕ 5-[4-(АЗЕТИДИН-3-ИЛОКСИ)ФЕНИЛ]-2-ФЕНИЛ-5Н-ТИАЗОЛО[5,4-c]ПИРИДИН-4-ОНА И ИХ ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ РЕЦЕПТОРОВ MCH
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
RU2018113296A (ru) Фармацевтическая композиция, содержащая 11-дезокси-простагландиновое соединение и способ стабилизации этого соединения
US6818638B2 (en) Melvinolin derivatives
JP2004529960A5 (US20040106767A1-20040603-C00005.png)
JP2006506381A5 (US20040106767A1-20040603-C00005.png)
JP2004519412A5 (US20040106767A1-20040603-C00005.png)
CA2445651A1 (en) Cathartic composition comprising halogenated prostaglandin derivatives
RU2006122935A (ru) Новые производные бензимидазола и имидазопиридина и их применение в качестве лекарственных средств
JP2007518685A5 (US20040106767A1-20040603-C00005.png)
JP2006518765A5 (US20040106767A1-20040603-C00005.png)
CA2502439A1 (en) Prostaglandin compounds for the treatment of obesity